In 1995 and 1996 the scientists of Eli Lilly and Aradigm Corporation met four times to discuss a potential collaboration between the two companies. Lilly had expertise in insulin compounds, and Aradigm had expertise in aerosol-based delivery systems. Nothing materialized.